Case Report of Prostate Leiomyosarcoma
Author Information
Author(s): Gerasimos P. Vandoros, Theodoros Manolidis, Michalis V. Karamouzis, Maria Gkermpesi, Maria Lambropoulou, Athanasios G. Papatsoris, Ioannis Zachos, Panagiotis A. Konstantinopoulos
Primary Institution: Aeghion General Hospital
Conclusion
Prostate leiomyosarcoma is a rare and aggressive cancer with a median survival of 17 months.
Supporting Evidence
- Prostate leiomyosarcoma accounts for less than 0.1% of primary prostate malignancies.
- Median survival for patients with metastatic disease at presentation was 5 months compared to 20 months for those without.
- Patients with negative surgical margins had a median survival of 41 months compared to 13 months for those with positive margins.
Takeaway
Prostate leiomyosarcoma is a very rare type of cancer that usually grows quickly and can spread to other parts of the body.
Methodology
The study reviewed 54 previously published cases and included a case report of a patient with prostate leiomyosarcoma.
Limitations
The study is retrospective and relies on previously published data, which may have variability in reporting.
Participant Demographics
The median age of patients was 63.8 years, with a range from 40 to 80 years.
Statistical Information
P-Value
0.018
Confidence Interval
95% CI 20.7–43.7 months
Statistical Significance
p = .018
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website